- Home
- KROS vs NDMO Comparison
KROS vs NDMO Comparison
Compare KROS & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NDMO
- Stock Information
- Founded
- KROS 2015
- NDMO 2019
- Country
- KROS United States
- NDMO United States
- Employees
- KROS N/A
- NDMO N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- KROS Health Care
- NDMO Finance
- Exchange
- KROS Nasdaq
- NDMO Nasdaq
- Market Cap
- KROS 460.6M
- NDMO 621.8M
- IPO Year
- KROS 2020
- NDMO N/A
- Fundamental
- Price
- KROS $11.12
- NDMO $10.58
- Analyst Decision
- KROS Buy
- NDMO
- Analyst Count
- KROS 11
- NDMO 0
- Target Price
- KROS $45.33
- NDMO N/A
- AVG Volume (30 Days)
- KROS 2.1M
- NDMO 218.6K
- Earning Date
- KROS 02-26-2025
- NDMO 01-01-0001
- Dividend Yield
- KROS N/A
- NDMO 6.75%
- EPS Growth
- KROS N/A
- NDMO N/A
- EPS
- KROS N/A
- NDMO N/A
- Revenue
- KROS $651,000.00
- NDMO N/A
- Revenue This Year
- KROS $303.27
- NDMO N/A
- Revenue Next Year
- KROS N/A
- NDMO N/A
- P/E Ratio
- KROS N/A
- NDMO N/A
- Revenue Growth
- KROS 8037.50
- NDMO N/A
- 52 Week Low
- KROS $9.78
- NDMO $8.99
- 52 Week High
- KROS $73.00
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- KROS 25.01
- NDMO 69.19
- Support Level
- KROS $11.04
- NDMO $10.33
- Resistance Level
- KROS $11.36
- NDMO $10.41
- Average True Range (ATR)
- KROS 0.53
- NDMO 0.08
- MACD
- KROS 1.15
- NDMO 0.03
- Stochastic Oscillator
- KROS 37.80
- NDMO 100.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.